SLC31A2
Chr 9solute carrier family 31 member 2
Also known as: COPT2, CTR2, hCTR2
The protein functions as a regulator of SLC31A1 by facilitating cleavage of the SLC31A1 ecto-domain and stabilizing its truncated form, thereby modulating endosomal copper export and cellular copper accumulation. Despite being predicted to cause disease through a dominant-negative mechanism, no specific diseases have been definitively associated with SLC31A2 mutations in humans. The gene shows high tolerance to loss-of-function variants, suggesting haploinsufficiency is unlikely to be pathogenic.
Population Genetics & Constraint
gnomAD v4 — loss-of-function & missense intolerance
Highly tolerant — LoF variants common in population
Mild missense constraint
This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.
Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.
Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.
ClinVar Variant Classifications
0 submitted variants in ClinVar
Protein Context — Lollipop Plot
SLC31A2 · protein map & ClinVar variants
Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.
External Resources
Links to major genomics databases and tools
Clinical Trials
Active and recruiting trials from ClinicalTrials.gov
No active trials found for this gene.
Search ClinicalTrials.gov →No open access results found
External Resources
Links to major genomics databases and tools